Rapid Micro Biosystems (RPID) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Rapid Micro Biosystems Revenue Highlights


Latest Revenue (Y)

$22.52M

Latest Revenue (Q)

$6.62M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Rapid Micro Biosystems Revenue by Period


Rapid Micro Biosystems Revenue by Year

DateRevenueChange
2023-12-31$22.52M31.44%
2022-12-31$17.13M-26.25%
2021-12-31$23.23M44.50%
2020-12-31$16.08M-2.63%
2019-12-31$16.51M-

Rapid Micro Biosystems generated $22.52M in revenue during NA 2023, up 31.44% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Rapid Micro Biosystems Revenue by Quarter

DateRevenueChange
2024-06-30$6.62M17.95%
2024-03-31$5.61M-11.46%
2023-12-31$6.34M3.12%
2023-09-30$6.14M22.85%
2023-06-30$5.00M-0.66%
2023-03-31$5.04M15.11%
2022-12-31$4.37M-7.70%
2022-09-30$4.74M22.77%
2022-06-30$3.86M-7.21%
2022-03-31$4.16M-20.12%
2021-12-31$5.21M-24.51%
2021-09-30$6.90M12.54%
2021-06-30$6.13M22.72%
2021-03-31$5.00M-4.64%
2020-12-31$5.24M-0.17%
2020-09-30$5.25M102.35%
2020-06-30$2.59M-13.54%
2020-03-31$3.00M-

Rapid Micro Biosystems generated $6.62M in revenue during Q2 2024, up 17.95% compared to the previous quarter, and up 131.44% compared to the same period a year ago.

Rapid Micro Biosystems Revenue Breakdown


Rapid Micro Biosystems Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Service$7.94M$6.08M-
Product$20.06M$11.06M-
Government Contract---
Product and service revenue - recurring--$7.82M
Product and service revenue - non-recurring--$13.82M
Non-commercial revenue - non-recurring--$1.59M

Rapid Micro Biosystems's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (71.63%), and Service (28.37%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Service$2.08M$1.96M$2.31M$2.08M$1.83M$1.71M$1.53M$1.53M-----
Product$4.92M$5.17M$7.88M$5.69M$3.17M$3.32M$2.84M$3.21M-----
Product and service revenue - recurring--------$2.50M$2.66M$2.28M$2.17M$1.90M
Product and service revenue - non-recurring--------$1.36M$1.50M$2.58M$4.13M$3.79M
Non-commercial revenue - non-recurring----------$353.00K$596.00K$436.00K

Rapid Micro Biosystems's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (70.26%), and Service (29.74%).

Rapid Micro Biosystems Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
JAPAN$2.56M--
All Other Countries$3.97M$2.96M-
GERMANY$2.12M$2.65M-
UNITED STATES$9.88M$8.77M-
SWITZERLAND$4.00M$2.76M-
Switzerland--$4.31M
United states--$12.89M
All other countries--$4.33M
Germany--$1.70M

Rapid Micro Biosystems's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (43.87%), SWITZERLAND (17.74%), All Other Countries (17.62%), JAPAN (11.38%), and GERMANY (9.40%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
SWITZERLAND$1.60M$972.00K$1.00M$1.06M$960.00K$973.00K$660.00K$608.00K-----
All Other Countries$1.01M$1.23M$777.00K$1.78M$853.00K$560.00K$988.00K$627.00K-----
GERMANY$970.00K$464.00K$724.00K$478.00K$501.00K$413.00K$411.00K$1.41M-----
UNITED STATES$2.66M$2.15M$2.89M$2.67M$2.62M$1.70M$2.31M$2.09M-----
JAPAN$372.00K$800.00K$941.00K$167.00K$68.00K$1.39M-------
All other countries--------$531.00K$815.00K$645.00K$1.39M$1.00M
Germany--------$401.00K$424.00K$432.00K$298.00K$636.00K
Switzerland--------$609.00K$879.00K$1.32M$899.00K$1.05M
United states--------$2.32M$2.04M$2.81M$4.31M$3.45M

Rapid Micro Biosystems's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (40.21%), SWITZERLAND (24.24%), All Other Countries (15.28%), GERMANY (14.66%), and JAPAN (5.62%).

Rapid Micro Biosystems Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova$1.15B$318.60M
BVSBioventus$512.35M$151.22M
AXGNAxoGen$159.01M$47.91M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
RXSTRxSight$89.08M$45.52M
LUNGPulmonx$68.67M$20.78M
IRIXIRIDEX$51.87M$12.63M
AZYOElutia$49.19M$6.13M
LNSRLENSAR$42.16M$10.59M
OSAProSomnus$27.65M$7.46M
RPIDRapid Micro Biosystems$22.52M$6.62M
VVOSVivos Therapeutics$13.80M$4.05M
INVOINVO Bioscience$3.02M$1.58M
TIVCTivic Health Systems$1.18M$140.00K
OWLTOwlet$800.00K$20.70M
TLISTalis Biomedical$412.00K-
AIMDAinos$122.11K-
OFIXOrthofix Medical$100.00K$198.62M
BJDXBluejay Diagnostics--
BBLGBone Biologics--

RPID Revenue FAQ


Rapid Micro Biosystems's yearly revenue for 2023 was $22.52M, representing an increase of 31.44% compared to 2022. The company's yearly revenue for 2022 was $17.13M, representing a decrease of -26.25% compared to 2021. RPID's yearly revenue for 2021 was $23.23M, representing an increase of 44.50% compared to 2020.

Rapid Micro Biosystems's quarterly revenue for Q2 2024 was $6.62M, a 17.95% increase from the previous quarter (Q1 2024), and a 32.31% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $5.61M, a -11.46% decrease from the previous quarter (Q4 2023), and a 11.44% increase year-over-year (Q1 2023). RPID's quarterly revenue for Q4 2023 was $6.34M, a 3.12% increase from the previous quarter (Q3 2023), and a 44.88% increase year-over-year (Q4 2022).

Rapid Micro Biosystems's revenue growth rate for the last 3 years (2021-2023) was -3.07%, and for the last 5 years (2019-2023) was 36.38%.

Rapid Micro Biosystems's revenue streams in c 23 are Service, and Product. Service generated $7.94M in revenue, accounting 28.37% of the company's total revenue, up 30.72% year-over-year. Product generated $20.06M in revenue, accounting 71.63% of the company's total revenue, up 81.44% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Rapid Micro Biosystems was Product. This segment made a revenue of $20.06M, representing 71.63% of the company's total revenue.